Minimally Invasive Direct Coronary Artery Bypass (MIDCAB)- Cardiology

Doctors: Cardiologist, Cardiac Surgeon

What is Minimally Invasive Direct Coronary Artery Bypass (MIDCAB) surgery?

MIDCAB is an open-heart bypass surgery in which an artery from the chest will be used to create a new blood supply to the heart muscle. The upper end of the artery is attached to a branch of the aorta so only the lower end is cut and repositioned.

The procedure:

Patient is given anesthesia. The surgery commonly takes around two to four hours. The surgeon will create a tiny, around two-and-a-half inch opening between two ribs in the left side of the chest.  A small operating camera (called a scope) and surgical instruments might be may be placed through 3 small incisions in the side of your chest between the ribs to take down the artery used to bypass the blocked heart vessels. An artery is harvested from the chest and is stitched to the coronary arteries through the keyhole-size opening.

All these steps are done while the heart is still beating, hence the patient do not need to be shifted to a heart-lung bypass machine. This would greatly decrease the risk of post-operative bleeding, stroke, and kidney failure.

What to expect after the procedure?

Patient would have some chest pain and will be given pain medications. Patient would be required to stay in hospital for certain number of days depending on his/her condition. Once the patient leaves the hospital, he/she will be required to visit the doctor’s office for regular follow-up.



Disclaimer: Please note that Mya Care does not provide medical advice, diagnosis, or treatment. The information provided is not intended to replace the care or advice of a qualified health care professional. The views expressed are personal views of the author and do not necessarily reflect the opinion of Mya Care. Always consult your doctor for all diagnoses, treatments, and cures for any diseases or conditions, as well as before changing your health care regimen. Do not reproduce, copy, reformat, publish, distribute, upload, post, transmit, transfer in any manner or sell any of the materials on this page without the prior written permission from

About the Author:

Dr. Anand Lakhkar is a physician scientist from India. He completed his basic medical education from India and his postgraduate training in pharmacology from the United States. He has a MS degree in pharmacology from New York Medical College, a MS degree in Cancer/Neuro Pharmacology from Georgetown University and a PhD in Pharmacology from New York Medical College where he was the recipient of the Graduate Faculty Council Award for academic and research excellence.  His research area of expertise is in pulmonary hypertension, traumatic brain injury and cardiovascular pharmacology.  He has multiple publications in international peer-reviewed journals and has presented his research at at prestigious conferences.